Dapagliflozin effect on functional mitral regurgitation and myocardial remodeling (DEFORM trial)

28 August 2023 (08:15 - 09:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Zhuoshan Huang

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou (China)

6 More presentations in this session

Presentation thumbnail

Impact of single-valve and multiple-valve heart disease on long-term outcome in patients with chronic heart failure

Doctor K. Hu (Wuerzburg, DE)

Abstract Slides Video

Presentation thumbnail

Comparison of non-invasive and invasive cardiac damage staging in patients with clinically significant aortic stenosis

Doctor M. Belmonte (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse

Mr A. Cesmat (Chapel Hill, US)

Abstract Slides Video

Presentation thumbnail

Cardiac damage extent in patient with isolated severe aortic stenosis referred to surgical aortic valve replacement: is it reversible after surgery?

Doctor M. Lima (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Epidemiology and prognostic relevance of morphofunctional classification of secondary mitral regurgitation

Doctor A. Provencio (Madrid, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Valvular disease and myocardial remodelling: a dangerous liaison

The Event

Event poster

ESC Congress 2023

28 August 2023 08:15 CET

You may be interested in

Congress Presentation

Effects on mitral and tricuspid valve regurgitation after 6 months of treatment with SGLT2 inhibitors in patients with chronic heart failure

Congress Presentation

Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients

Congress Presentation

Valvular heart disease in heart failure: how to treat it?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources